Gene dosage-dependent rescue of HSP neurite defects in SPG4 patients' neurons.
about
hiPSC-derived iMSCs: NextGen MSCs as an advanced therapeutically active cell resource for regenerative medicineTau missorting and spastin-induced microtubule disruption in neurodegeneration: Alzheimer Disease and Hereditary Spastic ParaplegiaHereditary spastic paraplegia SPG4: what is known and not known about the disease.Utility of Induced Pluripotent Stem Cells for the Study and Treatment of Genetic Diseases: Focus on Childhood Neurological DisordersDysfunction of spatacsin leads to axonal pathology in SPG11-linked hereditary spastic paraplegiaDefects in ER-endosome contacts impact lysosome function in hereditary spastic paraplegiaSpastin-interacting protein NA14/SSNA1 functions in cytokinesis and axon development.Clinical Trials in a Dish: The Potential of Pluripotent Stem Cells to Develop Therapies for Neurodegenerative Diseases.Mechanism of impaired microtubule-dependent peroxisome trafficking and oxidative stress in SPAST-mutated cells from patients with Hereditary Spastic Paraplegia.GSK3ß-dependent dysregulation of neurodevelopment in SPG11-patient iPSC model.Branch-Specific Microtubule Destabilization Mediates Axon Branch Loss during Neuromuscular Synapse Elimination.Human-induced pluripotent stem cells pave the road for a better understanding of motor neuron disease.Modeling Axonal Defects in Hereditary Spastic Paraplegia with Human Pluripotent Stem Cells.Pattern of Functional TTX-Resistant Sodium Channels Reveals a Developmental Stage of Human iPSC- and ESC-Derived NociceptorsHereditary spastic paraplegia-linked REEP1 modulates endoplasmic reticulum/mitochondria contacts.Truncating mutations of SPAST associated with hereditary spastic paraplegia indicate greater accumulation and toxicity of the M1 isoform of spastin.Alpha-synuclein prevents the formation of spherical mitochondria and apoptosis under oxidative stressOverexpression of KLC2 due to a homozygous deletion in the non-coding region causes SPOAN syndrome.Kdm6b and Pmepa1 as Targets of Bioelectrically and Behaviorally Induced Activin A Signaling.Insulin-like growth factor-1 regulation of retinal progenitor cell proliferation and differentiation.Re-engineered RNA-Guided FokI-Nucleases for Improved Genome Editing in Human Cells.Mutant spastin proteins promote deficits in axonal transport through an isoform-specific mechanism involving casein kinase 2 activation.Clinical spectrum and genetic landscape for hereditary spastic paraplegias in China.Sporadic Parkinson's disease derived neuronal cells show disease-specific mRNA and small RNA signatures with abundant deregulation of piRNAs.Patient-Derived Stem Cell Models in HSP: Disease Modelling and Drug Discoveryα-Synuclein oligomers induce early axonal dysfunction in human iPSC-based models of synucleinopathiesBMP- and neuropilin 1-mediated motor axon navigation relies on spastin alternative translationFunctional differences of short and long isoforms of spastin harboring missense mutation
P2860
Q26751506-6F4F1154-4395-477E-B788-E3F144B450CAQ26774045-327D3CB2-837D-4A39-8453-EC921B4C8F0CQ27690406-EBDA1B9C-2389-4416-A6A6-227E83206DFDQ28080219-322F0518-925F-4577-9C5A-3393C9F16D37Q28115985-81D68EA4-81EC-4AB2-A370-2EB2115033EAQ33625326-EFFC51A9-63A2-4910-9BDF-2044EB7D7D8CQ34497770-A23DFB69-2FD4-4A9F-97C8-1A3DB04C95D2Q36904682-A39BC96E-B491-4A54-94C6-7776AF54CBFFQ36941323-54ABA15B-7118-4590-B2B3-CE72D45A7234Q37375578-94FAC08D-88F7-4D90-A820-F3107065548DQ37463947-3454FDC3-4040-4210-8BEA-2F03C41EFB77Q38211417-290B4F56-52B2-4F2F-9639-F107E583020DQ38783743-ABBCA2E1-9A2A-429D-B449-D5BCBD02FD1EQ38839506-71AA03BF-15EC-4715-BFD1-0E3F219BD842Q40707464-FC6EA2BE-FDCC-4A87-9363-A8C5E8406AE3Q41001513-AD79CCA0-8E0C-4F3A-B8D1-4D49B0EFBE58Q42320467-F6BC081D-CAAE-4207-AA33-4682A4BF0514Q46045806-9F32EC88-75CF-42A7-8E20-68A7FE30E385Q48077289-500D0B35-93F7-4D4F-BA2B-A7550C569B51Q48506728-E265CE98-1382-4209-9E4F-044A815DA894Q50281015-402B1DB2-7470-4E6B-B567-A7C0B6DE5F75Q51063673-68486F05-8D34-47E5-865B-F4C6A08A0976Q55510355-6FF48276-C054-471A-9709-69649B2A560EQ55717563-563D9CD3-57C1-46DD-B37F-D5BBD6E4DBEFQ57155504-150462A0-ED5C-408D-9F9A-EC281F882375Q57990760-C21C4EBA-6B6C-4BC8-885E-6AB63DA67333Q58746716-7CC14695-F561-41E4-A699-B7D5D91A1BC7Q58752900-128BC2DB-B24C-4314-A09E-2DEC4DCF0C7C
P2860
Gene dosage-dependent rescue of HSP neurite defects in SPG4 patients' neurons.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 30 December 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Gene dosage-dependent rescue of HSP neurite defects in SPG4 patients' neurons.
@en
Gene dosage-dependent rescue of HSP neurite defects in SPG4 patients' neurons.
@nl
type
label
Gene dosage-dependent rescue of HSP neurite defects in SPG4 patients' neurons.
@en
Gene dosage-dependent rescue of HSP neurite defects in SPG4 patients' neurons.
@nl
prefLabel
Gene dosage-dependent rescue of HSP neurite defects in SPG4 patients' neurons.
@en
Gene dosage-dependent rescue of HSP neurite defects in SPG4 patients' neurons.
@nl
P2093
P2860
P50
P356
P1476
Gene dosage-dependent rescue of HSP neurite defects in SPG4 patients' neurons.
@en
P2093
Esther Eberhardt
Fred H Gage
Himanshu K Mishra
Holger Wend
Jürgen Winkler
Maria C N Marchetto
Naime Denguir
Sonja Plötz
Steven Havlicek
Teja W Groemer
P2860
P304
P356
10.1093/HMG/DDT644
P50
P577
2013-12-30T00:00:00Z